Painful hemorrhagic nodule on the chin
DOI:
https://doi.org/10.66344/jpad.19.2.2009.525References
Miller SJ. Continuing medical education: biology of basal cell carcinoma (part 1) J Am Acad Dermatol 1991; 24: 1-13.
Miller SJ. Continuing medical education: biology of basal cell carcinoma. (part 2). J Am Acad Dermatol 1991; 24: 161-75.
CSM Wong, RG Strange, JT Lear. Basal cell carcinoma. BMJ 2003; 327: 794-806.
Von Domarus H, Stevens PJ. Metastatic basal cell carcinoma: report of five cases and review of 170 cases in literature. J Am Acad Dermatol 1984; 10: 1043-60.
Dhir A, Orengo I, Bruce S. Basal cell carcinoma on the scalp of an Indian patient. Dermatol Surg 1995; 21: 247-50.
Kumar N, Saxena YK. Two cases of rare presentation of basal cell and squamous cell carcinoma on the hand. Indian J Dermatol Venereol Leprol 2002; 68: 349-51.
Kulkarni P, Brashear R, Chuang TY. Nevoid basal cell carcinoma syndrome in a person with dark skin. J Am Acad Dermatol 2003; 49: 332-5.
Koh D, Wang H, Lee J et al. Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry data 1968-97. Br J Dermatol 2003; 148: 1161-6.
Johnson TM, Theodore A, Swanson NA. Combined curettage and excision: A treatment method for primary basal cell carcinoma. J Am Acad Dermatol 199; 26: 613-7.
Braathen LR, Szeimies RM, Basset-Seguin N et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007; 56: 125-43.
Greenway HT, Cornell RC, Tanner DJ et al. Treatment of basal cell carcinoma with intralesional interferon. J Am Acad Dermatol 1986; 15: 437-43.
Geisse J, Caro I, Lindholm J et al Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004; 50: 722-33.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
